Feasibility of Eribulin Mesylate in older patients with locally advanced or metastatic breast cancer: A post-hoc analysis of the ESEMPiO study

ESEMPiO Group

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
Pages (from-to)990-993
Number of pages4
JournalJournal of Geriatric Oncology
Volume10
Issue number6
DOIs
Publication statusPublished - Nov 1 2019

Keywords

  • Aged
  • Eribulin
  • Metastatic breast cancer
  • Safety

ASJC Scopus subject areas

  • Oncology
  • Geriatrics and Gerontology

Cite this